Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tulsi Amrit is an Indian healthcare company specializing in the development and manufacture of Ayurvedic and herbal wellness products. The company is widely recognized for its flagship product, Panch Tulsi Amrit, which is a concentrated liquid extract derived from five distinct species of the Tulsi (Holy Basil) plant. Their product portfolio is centered on traditional Ayurvedic principles, focusing on natural solutions for immune support, respiratory health, and detoxification. Tulsi Amrit operates primarily in the consumer healthcare sector, distributing its herbal formulations through a network of retail and online channels. The company emphasizes the use of natural ingredients to provide holistic health benefits without the side effects often associated with synthetic pharmaceuticals. By integrating ancient herbal wisdom with modern quality standards, Tulsi Amrit has established itself as a notable player in the Indian natural supplements market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tulsi Amrit.